Is overall asthma control being achieved? A hypothesis-generating study

被引:78
作者
Bateman, ED
Bousquet, J
Braunstein, GL
机构
[1] Univ Cape Town, UCT Lung Inst, ZA-7937 Cape Town, South Africa
[2] Hop Arnaud de Villeneuvre, Montpellier, France
[3] GlaxoSmithkline Res & Dev, Uxbridge, Middx, England
关键词
asthma control; budesonide; drug therapy; fluticasone propionate; guidelines; salmeterol;
D O I
10.1183/09031936.01.17405890
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The efficacy of asthma therapy is traditionally measured using single end-points. In contrast, the aim of therapy is to achieve overall control, defined by management guidelines as achieving a number of treatment goals. These goals reflect expert opinion, rather than being evidence based. The objective of this study was to determine whether guideline-defined asthma control is achievable. Eight studies of salmeterol/fluticasone propionate combination therapy were analysed using three asthma control measures of varying stringency, derived from the guideline goals, For each measure, only patients meeting all goals were classified as controlled. The analysis demonstrated that asthma control, as defined by management guidelines, can be achieved, For a given therapy, similar proportions of patients achieved control irrespective of disease severity, suggesting that outcome expectations should not be reduced for patients with more severe disease. Substantially more patients achieved the target values for individual goals than achieved overall control, indicating that reliance on individual end-points is likely to result in significant overestimation of true control. The findings of this hypothesis-generating study should be prospectively tested, Future research mill include a randomized controlled study designed to assess the proportion of patients able to achieve overall control of asthma when treatment is titrated appropriately.
引用
收藏
页码:589 / 595
页数:7
相关论文
共 22 条
[1]   Salmeterol/fluticasone propionate (50/500 μg) in combination in a Diskus® inhaler (Seretide®) is effective and safe in the treatment of steroid-dependent asthma [J].
Aubier, M ;
Pieters, WR ;
Schlösser, NJJ ;
Steinmetz, KO .
RESPIRATORY MEDICINE, 1999, 93 (12) :876-884
[2]   Salmeterol/fluticasone combination inhaler - A new, effective and well tolerated treatment for asthma [J].
Bateman, ED ;
Britton, M ;
Carrillo, J ;
Almeida, J ;
Wixon, C .
CLINICAL DRUG INVESTIGATION, 1998, 16 (03) :193-201
[3]  
*BRIT THOR SOC, 1997, THORAX S1, V52, pS1, DOI DOI 10.1136/THX.52.2008.S1]
[4]  
Chapman K R, 1999, Can Respir J, V6, P45
[5]   Asthma control versus asthma severity [J].
Cockcroft, DW ;
Swystun, VA .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (06) :1016-1018
[6]   Salmeterol/fluticasone propionate combination therapy 50/250 μg twice daily is more effective than budesonide 800 μg twice daily in treating moderate to severe asthma [J].
Jenkins, C ;
Woolcock, AJ ;
Saarelainen, P ;
Lundbäck, B ;
James, MH .
RESPIRATORY MEDICINE, 2000, 94 (07) :715-723
[7]  
Johansson G, 1999, AM J RESP CRIT CARE, V159, pA637
[8]   Measuring asthma control - Clinic questionnaire or daily diary? [J].
Juniper, EF ;
O'Byrne, PM ;
Ferrie, PJ ;
King, DR ;
Roberts, JN .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (04) :1330-1334
[9]   Development and validation of a questionnaire to measure asthma control [J].
Juniper, EF ;
O'Byrne, PM ;
Guyatt, GH ;
Ferrie, PJ ;
King, DR .
EUROPEAN RESPIRATORY JOURNAL, 1999, 14 (04) :902-907
[10]   Validation of a standardized version of the Asthma Quality of Life Questionnaire [J].
Juniper, EF ;
Buist, AS ;
Cox, FM ;
Ferrie, PJ ;
King, DR .
CHEST, 1999, 115 (05) :1265-1270